Peptide library / Hormones & metabolism / CJC-1295
CJC-1295
A modified growth hormone-releasing hormone, often paired with ipamorelin.
Effects studied or claimed
What it is used or promoted for, and where each effect has actually been seen
- Growth hormone and IGF-1 elevationSmall human studies
- Anti-aging and body composition, promotedLab
How it is thought to work
CJC-1295 stimulates growth hormone release from the pituitary. A version with drug affinity complex binds blood albumin so that it lasts days instead of minutes.
What the evidence shows
A small study in healthy adults showed raised growth hormone and IGF-1 for days after a single dose. There are no large trials of clinical outcomes.
Safety and unknowns
Flushing, injection site reactions and water retention have been reported. The original sponsor discontinued development.
Regulatory status
Not approved. Banned in sport.
Regulatory status changes quickly. This entry was last reviewed on 27 October 2026. Confirm current status with the FDA before relying on it.
More in Hormones & metabolism
Corticotropin
FDA-approvedA long-acting form of ACTH, the hormone that tells the adrenal glands to make cortisol.
Cosyntropin
FDA-approvedThe first 24 amino acids of ACTH, used as a test for adrenal insufficiency.
Vasopressin
FDA-approvedA nine amino acid hormone used to raise blood pressure in vasodilatory shock.
General information, not medical advice. Do not buy or inject unregulated peptides.